Company Overview and News

 
PT&T plans P7-B fund raising for broadband expansion

2018-09-20 bworldonline
PHILIPPINE Telegraph and Telephone Corp. (PT&T) is looking to raise P7 billion for its plan to expand its fixed line coverage throughout the country over the next two years.
PSKXF PHSXY PSE PTT

 
PT&T to start debt-to-equity conversion next month in bid to be third telco

2018-09-18 bworldonline
PHILIPPINE Telegraph and Telephone Corp. (PT&T) is set to start by next month the implementation of its debt-to-equity conversion, in line with its exit from court-assisted rehabilitation as granted by a Makati City Regional Trial Court (RTC).
PSKXF PHSXY PSE PTT

 
PT&T willing to pay any penalty imposed by PSE

2018-09-04 bworldonline
THE Philippine Telegraph and Telephone Corp. (PT&T) on Tuesday said it is willing to settle any remaining penalties the Philippine Stock Exchange (PSE) may impose, as well as comply with the requirements that may pave the way for the lifting of its trading suspension.
PSKXF PHSXY PSE PTT

 
PT&T gets go-signal to exit corporate rehabilitation

2018-08-08 bworldonline
THE Philippine Telegraph and Telephone Corp. (PT&T) said a Makati Regional Trial Court (RTC) granted its request to exit from court-assisted corporate rehabilitation, giving a boost to its plan to participate in the bidding for the third telecommunications player.
PTT

 
Court grants PT&T appeal for rehab exit

2018-08-08 bworldonline
The Philippine Telegraph and Telephone Corp. (PT&T) said the regional trial court (RTC) of Makati City has granted its appeal to leave its court-assisted corporate rehabilitation.
PTT

 
PT&T appeals for rehab exit

2018-08-01 bworldonline
THE PHILIPPINE Telegraph and Telephone Corp. (PT&T) has appealed to the regional trial court (RTC) of Makati City to be allowed to leave its court-assisted corporate rehabilitation to proceed with its operations.
PTT

 
Velasquez takes over PT&T

2018-06-29 bworldonline
PHILIPPINE Telegraph and Telephone Corp. (PT&T) has formalized the election and appointment of James G. Velasquez as the company’s new president and chief executive officer, replacing Benjamin M. Bitanga.
PTT

 
PT&T names new CEO

2018-06-29 bworldonline
The Philippine Telegraph and Telephone Corporation (PT&T) has formalized the election and appointment of James G. Velasquez as the company’s new president and chief executive officer, replacing Benjamin M. Bitanga.
PTT

 
PT&T settles P7-M SEC fine for failure to comply with reportorial requirements

2018-06-21 bworldonline
THE PHILIPPINE Telegraph and Telephone Corp. (PT&T) on Thursday said it has paid the P7-million fine slapped by the Securities and Exchange Commission (SEC) for its failure to submit audited financial statements and annual reports, among others.
PTT

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to PSE:PTT / Philippine Telegraph and Telephone Corporation on message board site Silicon Investor.

OPTEK TECHNOLOGY (OPTT) OPTEK TECHNOLOGY (OPTT) OPTEK TECHNOLOGY (OPTT)